Longitudinal measurement of disease activity in a MM patient with del13.

The patient presented with a combination a unfavorable prognostic features including del13. After allogeneic bone marrow transplantation performed during relapse, he went into sustained clinical (A) and molecular (B) remission. Remarkable residual MM cells were detected by quantitative PCR more than 3 years after disappearance of myeloma proteins (B).